HbA1c News and Research

RSS
The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Diabetes remission possible even without significant weight loss after gastric bypass surgery

Diabetes remission possible even without significant weight loss after gastric bypass surgery

Study challenges link between added sugar intake and prediabetes risk

Study challenges link between added sugar intake and prediabetes risk

Is there an association between COVID-19 vaccination and changes in ovarian reserve?

Is there an association between COVID-19 vaccination and changes in ovarian reserve?

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Closed-loop system appears to be safe and superior to usual care in controlling glucose in children with type 1 diabetes

Closed-loop system appears to be safe and superior to usual care in controlling glucose in children with type 1 diabetes

SCORE 2D predicts risk of cardiovascular disease in patients with diabetes

SCORE 2D predicts risk of cardiovascular disease in patients with diabetes

Managing blood sugar levels during exercise remains a challenge for people with type 1 diabetes

Managing blood sugar levels during exercise remains a challenge for people with type 1 diabetes

Analysis of remission and relapse rate of type 2 diabetes mellitus in Japan

Analysis of remission and relapse rate of type 2 diabetes mellitus in Japan

New study reveals alarming impact of ultra-processed foods on cardiometabolic health

New study reveals alarming impact of ultra-processed foods on cardiometabolic health

Study: One in three people with Type 2 diabetes in Austria suddenly stop treatment

Study: One in three people with Type 2 diabetes in Austria suddenly stop treatment

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

Low-carb breakfast tames glucose spikes in type 2 diabetes

Low-carb breakfast tames glucose spikes in type 2 diabetes

Is there radiographic evidence of premature brain aging in individuals with type 1 diabetes?

Is there radiographic evidence of premature brain aging in individuals with type 1 diabetes?

Pilot study reveals effective approach to boost adherence to Mediterranean ketogenic diet for memory concerns in older adults

Pilot study reveals effective approach to boost adherence to Mediterranean ketogenic diet for memory concerns in older adults

SCORE2- diabetes prediction model estimates the 10 year risk of cardiovascular disease in individuals with type 2 diabetes

SCORE2- diabetes prediction model estimates the 10 year risk of cardiovascular disease in individuals with type 2 diabetes

Precision nutrition vs. low-fat diet: No significant difference in diabetes management

Precision nutrition vs. low-fat diet: No significant difference in diabetes management

Study shows an association between type 2 diabetes and developing dementia in later life

Study shows an association between type 2 diabetes and developing dementia in later life

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.